UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
AEHR TEST SYSTEMS
-----------------------------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------------------------
(Title of Class of Securities)
00760J108
-----------------------------------------------------------------------
(CUSIP Number)
Rhea J. Posedel
C/O Aehr Test Systems
400 Kato Terrace
Fremont, CA 94539
(510-623-9400)
-----------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 13, 2015
-----------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D,
and is filing this schedule because of the Sections 240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box: / /
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits. See
Rule 240.13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
SCHEDULE 13D
CUSIP No. 00760J108
-----------------------------------------------------------------------
(1) NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE
PERSON
Rhea J. Posedel.
-----------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) / /
(b) /x/
-----------------------------------------------------------------------
(3) SEC USE ONLY
-----------------------------------------------------------------------
(4) SOURCE OF FUNDS (See Instructions)
PF
-----------------------------------------------------------------------
(5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) / /
-----------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
-----------------------------------------------------------------------
Number of (7) SOLE VOTING POWER 1,210,768
Shares --------------------------------------------
Beneficially (8) SHARED VOTING POWER 0
Owned by --------------------------------------------
Each (9) SOLE DISPOSITIVE POWER 1,210,768
Reporting --------------------------------------------
Person With (10) SHARED DISPOSITIVE POWER 0
-----------------------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,210,768
-----------------------------------------------------------------------
(12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See Instructions) / /
-----------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.4%
-----------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON (See Instructions)
IN
-----------------------------------------------------------------------
Item 1. Security and the Issuer
This statement on Schedule 13D (this "Statement") relates to
the shares of common stock, par value $0.01 per share (the
"Common Stock"), of Aehr Test Systems, a Delaware corporation
(the "Issuer"). The principal executive offices of the Issuer
are located at 400 Kato Terrace, Fremont, CA 94539.
Item 2. Identity and Background
(a) This Statement is filed on behalf of Rhea J. Posedel ("Mr.
Posedel")
(b) The address of Mr. Posedel is 400 Kato Terrace, Fremont, CA
94539.
(c) Mr. Posedel is a founder of the Company and is presently
Chairman of the Board of Directors; he has held this
position since the Company formation. Additionally, he has
held several positions in the Company: Executive Chairman
from January 2012 to March 2013, Chief Executive Officer
from 1977 through January 2012, and President from 1977
through May 2000.
(d) Mr. Posedel has not, during the last five years, been
convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors).
(e) Mr. Posedel has not, during the last five years, been a
party to a civil proceeding of a judicial or administrative
body of competent jurisdiction as a result of which such
Reporting Person was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state
securities laws or finding any violation with respect to
such laws.
(f) Mr. Posedel is a citizen of the United States of America.
Item 3. Source and Amount of Funds or other Consideration
The funds used by Mr. Posedel to acquire beneficial ownership
of the Issuer's Common Stock were personal funds.
Item 4. Purpose of Transaction
Mr. Posedel acquired the Company's stock for investment
purposes.
Item 5. Interest in Securities of the Issuer
(a) The aggregate percentage of Common Stock reported to be
owned by the Reporting Persons is based upon 12,833,280
shares of Common Stock outstanding, which is the total
number of shares outstanding as of this filing date, and
assumes the exercise of the 150,468 options held by Mr.
Posedel which are exercisable within 60 days of this
filing date.
Mr. Posedel may be deemed to beneficially own in the
aggregate 1,210,768 shares of Common Stock, representing
approximately 9.4% of the outstanding shares of Common
Stock.
(b) Mr. Posedel owns 44,686 shares of Common Stock directly,
and 150,468 options to purchase shares of Common stock
which are exercisable within 60 days of this filing date.
Rhea J. Posedel Family Trust, of which Mr. Posedel is
Trustee, and has sole voting and dispositive power, owns
1,015,614 shares of Common Stock.
(c) None.
(d) No person other than Mr. Posedel, has the right to receive
or the power to direct the receipt of dividends from, or the
proceeds from the sale of, the shares of Common Stock set
forth above.
(e) Not applicable
Item 6. Contracts, Arrangements, Understandings or Relationships
with Respect to Securities of the Issuer
None.
Item 7. Material to Be Filed as Exhibits
None.
SIGNATURE
After reasonable inquiry and to the best of each of the undersigned's
knowledge and belief, each of the undersigned, severally and not
jointly, certifies that the information set forth in this statement is
true, complete and correct.
Dated: February 13, 2015
RHEA J. POSEDEL.
By: /S/ Rhea J. Posedel
------------------------
Name: Rhea J. Posedel
Dated: February 13, 2015
Rhea J. Posedel Family Trust
By: /S/ Rhea J. Posedel
-----------------------------
Rhea J. Posedel ,Trustee